Substance use disorders are widespread in the US, but many people wrongly equate detoxing with being cured.
Articles on Benzodiazepines
Displaying all articles
The study offers insight into how marijuana access may alter treatment patterns for patients with anxiety.
Clonazepam is twenty times more potent than Valium, and the effects last a lot longer.
Synthetic opioids called nitazenes are ones to watch in 2024.
There were more than 100,000 opioid-related deaths in North America in 2022. How the crisis grew to such proportions, and three potential paths to ending it.
Sedative-hypnotic drugs can distort a patient’s perception of reality. Some patients wake up from a procedure believing they have been sexually assaulted.
As British Columbia begins a new era in drug policy, the drug poisoning crisis continues without an end in sight.
People are dying from using a toxic drug supply. Safer supply and other approaches that listen to the needs of people who use drugs are critical to saving lives and addressing the opioid crisis.
Fentanyl adulteration led to the replacement of heroin in the unregulated drug supply of British Columbia. Now that benzodiazepines are present in many opioids, are we headed towards a ‘new normal?’
Benzodiazepines, or benzos, are some of the most widely prescribed drugs in the US. They are meant to be used only short-term, but thousands use them long-term. That’s a big worry.
With so many different types out there, it’s hard to know what sleep medications are safe to use. Here’s a guide.
More young people are using Xanax – but overdose, addiction and side effects present serious risks.
Benzodiazepines are used by many people despite their associated risks and harms.
Opiates have emerged as a significant threat to public health in the UK.
Benzodiazepines, like alcohol, are depressant drugs, sometimes referred to as “downers” as they make people feel relaxed, sleepy, less coordinated and generally slowed down.
The body responsible for regulating drugs in Australia, the Therapeutic Goods Administration (TGA), is poised to decide whether to restrict access to benzodiazepines, such as Xanax, Valium and Normison…
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor of Forensic Science, Anglia Ruskin University
-
PhD Candidate, School of Population and Public Health, University of British Columbia
-
Adjunct Research Fellow, Swinburne University of Technology
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Head of School and Dean of Pharmacy, University of Sydney
-
Professor and Executive Dean of School, Medical and Health Sciences, Edith Cowan University
-
Professor of Epidemiology, NDARC, UNSW
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor, Anglia Ruskin University
-
Assistant Professor, Dept of Medicine, University of British Columbia and Research Scientist with the BC Centre on Substance Use, University of British Columbia
-
Ph.D. Candidate in Pharmaceutical Sciences, University of Connecticut
-
Assistant Professor, Department of Medicine, University of British Columbia
-
PhD candidate, Dalla Lana School of Public Health, University of Toronto
-
Post Doctoral Fellow, British Columbia Centre on Substance Use, University of British Columbia